Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.48 USD | +3.62% | -1.43% | +37.73% |
Apr. 03 | XOMA Corporation completed the acquisition of Kinnate Biopharma Inc.. | CI |
Mar. 08 | XOMA Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on XOMA Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering XOMA Corporation
HC Wainwright | |
Wedbush | |
Aegis Capital |
EPS Revisions
- Stock Market
- Equities
- XOMA Stock
- Consensus XOMA Corporation